Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pneumatic Compression Reduces Lymphedema Consequences

By HospiMedica International staff writers
Posted on 14 Oct 2015
Lymphedema patients saw a nearly 80% reduction in their cellulitis episodes by using an advanced pneumatic compression device (APCD) at home, according to a new study.

Researchers at Vanderbilt University (Nashville, TN, USA) and the University of Minnesota (UMN; Minneapolis, USA) conducted a retrospective analysis involving 718 patients (both with and without cancer) to examine the impact of an APCD on cutaneous and other clinical outcomes, as well as health economic costs. More...
The researchers compared outcomes for the year before and after APCD purchase, with the main outcomes and measures including rates of cellulitis, use of lymphedema-related manual therapy, and outpatient and inpatient hospitalizations.

The results showed that APCD use was associated with reduction in cellulitis episodes, lymphedema-related manual therapy, and outpatient visits. Among the cancer cohort, total lymphedema-related costs per patient were reduced by 37% (from USD 2,597 to USD 1,642). Reductions in physical therapy and outpatient visits resulted in a 37% decrease in lymphedema-related costs per patient, excluding medical equipment, among those with cancer, and a 36% decrease in costs for the non-cancer cohort. The study was published on October 7, 2015, in JAMA Dermatology.

“This could be a game-changer in the area of lymphedema care. Up to 10 million people in the United States are living and oftentimes suffering with symptoms of lymphedema,” said study co-lead author Prof. Sheila Ridner, PhD, of Vanderbilt University School of Nursing. “The idea that a home advanced pneumatic compression device can provide relief, decrease the number of cellulitis episodes, and save money is an important new option for patients.”

“Patients with lymphedema turn to dermatologists, primary care, and vascular physicians for treatment, and now these providers have a therapy to improve skin, limb, and systemic health for these individuals,” said Jerry Mattys, CEO of Tactile Medical (Minneapolis, MN, USA), which developed the Flexitouch APCD system used in the study. “This device sequentially inflates over areas of the body affected by lymphedema to facilitate the movement of excess fluid from the limb back to the cardiovascular system.”

Lymphedema is an accumulation of fluid in tissues commonly caused by abnormalities in the lymphatic system or removal or damage to a person's lymph nodes. Symptoms include swelling, recurrent cellulitis, loss of physical function, psychological stress and diminished quality of life. Lymphedema cannot be cured and is typically managed through combined therapies of manual lymph drainage, multilayer bandaging, decongestive exercise, skin care, and long-term self-management.

Related Links:

Vanderbilt University
University of Minnesota
Tactile Medical



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.